K. Kolodner - Concepedia

Concepedia

Author

K. Kolodner

Johns Hopkins University

Also Known As

K B Kolodner, K Kolodner, K. B. Kolodner, K. Kolodner

9

Publications

1.5K

Citations

9

H-Index

22

Concepts

All Affiliations

Johns Hopkins University

KK

About

K. Kolodner is an author at Johns Hopkins University specializing in pharmacotherapy, neuropharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	35
2	Education	1	1	134
3	Social Sciences	1	1	134
4	Behavioral Sciences	1	1	134
5	Geriatrics	1	1	11

K. Kolodner

×

9

Publications

1.5K

Citations

9

H-Index

	Year	Citations
An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score Walter F. Stewart, Richard B. Lipton, James Whyte, Neurology	1999	606
The Prevalence and Disability Burden of Adult Migraine in England and their Relationships to Age, Gender and Ethnicity TJ Steiner, WF Stewart, K. Kolodner, Cephalalgia	2003	438
Prevalence and impact of migraine and probable migraine in a health plan Nitin Patel, Marcelo E. Bigal, K. Kolodner, Neurology	2004	153
Social competence interview for assessing physiological reactivity in adolescents. Craig K. Ewart, K. Kolodner Psychosomatic Medicine Social PsychologyEducationMental HealthSocial SciencesPsychology	1991	134
Familial risk of migraine W. F. Stewart, Marcelo E. Bigal, K. Kolodner, Neurology	2006	100
Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination Richard B. Lipton, Marcelo E. Bigal, K. Kolodner, Neurology Cluster HeadachePreemptive TreatmentMedicineNeuropharmacologyPharmacotherapy	2004	24
Predictors of variability in urinary incontinence and overactive bladder symptoms Walter F. Stewart, Vatché A. Minassian, Annemarie G. Hirsch, Neurourology and Urodynamics	2009	21
Diminished pulse pressure response to psychological stress: early precursor of essential hypertension? Craig K. Ewart, K. Kolodner Psychosomatic Medicine	1992	18
513 Darifenacin, an M3 selective receptor antagonist for the treatment of overactive bladder, does not affect cognitive function in elderly volunteers Keith Wesnes, Richard A. Lipton, K. Kolodner, European Urology Supplements Molecular PharmacologyUrologyVoiding DysfunctionGeriatricsMedicine	2004	11

Page 1